Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Instem stock price, quote, forecast and news

INS.L
GB00B3TQCK30
A1C7NS

Price

8.30
Today +/-
+0
Today %
+0 %
P

Instem Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Instem, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Instem from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Instem’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Instem. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Instem’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Instem’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Instem’s growth potential.

Instem Revenue, EBIT and net profit per share

DateInstem RevenueInstem EBITInstem Net Income
2026e90.28 M undefined21.27 M undefined13.48 M undefined
2025e84.1 M undefined14.52 M undefined11.65 M undefined
2024e75.86 M undefined11.54 M undefined9.18 M undefined
2023e67.21 M undefined9.06 M undefined7.27 M undefined
202257.63 M undefined6.5 M undefined4.7 M undefined
202146.02 M undefined4.77 M undefined1.68 M undefined
202028.22 M undefined3.81 M undefined2.27 M undefined
201925.72 M undefined2.83 M undefined-920,000 undefined
201822.71 M undefined2.38 M undefined1.47 M undefined
201721.07 M undefined820,000 undefined640,000 undefined
201618.32 M undefined50,000 undefined1.06 M undefined
201516.32 M undefined1.34 M undefined-430,000 undefined
201413.43 M undefined680,000 undefined150,000 undefined
201311.36 M undefined960,000 undefined530,000 undefined
201210.66 M undefined1.02 M undefined1.04 M undefined
201110.79 M undefined1.57 M undefined1.01 M undefined
201010 M undefined2.2 M undefined900,000 undefined
20099.99 M undefined2.14 M undefined1.71 M undefined
20088.81 M undefined1.91 M undefined-350,000 undefined
20077.99 M undefined1.77 M undefined700,000 undefined

Instem Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20072008200920102011201220132014201520162017201820192020202120222023e2024e2025e2026e
7891010101113161821222528465767758490
-14.2912.5011.11--10.0018.1823.0812.5016.674.7613.6412.0064.2923.9117.5411.9412.007.14
----100.00100.00100.00100.0093.7594.4490.4895.4596.0092.8695.65-----
0000101011131517192124264400000
11221100100223469111421
14.2912.5022.2220.0010.0010.00--6.25--9.098.0010.718.7010.5313.4314.6716.6723.33
0010110001010214791113
---------------50.00300.0075.0028.5722.2218.18
0.930.936.497.7211.8511.7611.7812.2212.415.6316.1616.8516.2519.6522.7223.690000
--------------------
Details

Keystats

ⓘ

Revenue and Growth

The Instem Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Instem is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Instem provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Instem's financial health and stability.

Assets

Instem's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Instem must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Instem after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Instem's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (k)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2007200820092010201120122013201420152016201720182019202020212022
1021110000010225
0000000111112234
0000000000000000
-1,000-2,0001,000-1,000-1,000-1,00000000-1,0001,0001,0001,000-2,000
0100000010003001
0000000000000000
0000000000000001,000
0030001020125697
000000000-1-1-1-1-1-2-3
000000-20-1-3-2-1-2-1-17-3
000000-100-200-10-150
0000000000000000
000-700000000000-1
00090000040001500
000000000400015-3-6
---------------2.00-5.00
0000000000000000
0030000002-10220-11-1
0.05-0.773.29-0.560.06-0.571.37-0.011.77-0.87-0.240.563.985.536.824.36
0000000000000000

Instem stock margins

The Instem margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Instem. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Instem.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Instem's sales revenue. A higher gross margin percentage indicates that the Instem retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Instem's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Instem's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Instem's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Instem. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Instem's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Instem Margin History

Instem Gross marginInstem Profit marginInstem EBIT marginInstem Profit margin
2026e96.26 %23.56 %14.93 %
2025e96.26 %17.27 %13.86 %
2024e96.26 %15.21 %12.1 %
2023e96.26 %13.49 %10.81 %
202296.26 %11.27 %8.15 %
202196.26 %10.37 %3.65 %
202094.51 %13.5 %8.04 %
201994.32 %11 %-3.58 %
201895.11 %10.48 %6.47 %
201792.03 %3.89 %3.04 %
201696.72 %0.27 %5.79 %
201596.38 %8.21 %-2.63 %
201498.59 %5.06 %1.12 %
201399.03 %8.45 %4.67 %
201295.97 %9.57 %9.76 %
201198.98 %14.55 %9.36 %
201096.26 %22 %9 %
200996.26 %21.42 %17.12 %
200896.26 %21.68 %-3.97 %
200796.26 %22.15 %8.76 %

Instem Stock Sales Revenue, EBIT, Earnings per Share

The Instem earnings per share therefore indicates how much revenue Instem has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Instem earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Instem's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Instem’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Instem's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Instem Revenue, EBIT and net profit per share

DateInstem Sales per ShareInstem EBIT per shareInstem Earnings per Share
2026e3.75 undefined0 undefined0.56 undefined
2025e3.5 undefined0 undefined0.48 undefined
2024e3.15 undefined0 undefined0.38 undefined
2023e2.79 undefined0 undefined0.3 undefined
20222.43 undefined0.27 undefined0.2 undefined
20212.03 undefined0.21 undefined0.07 undefined
20201.44 undefined0.19 undefined0.12 undefined
20191.58 undefined0.17 undefined-0.06 undefined
20181.35 undefined0.14 undefined0.09 undefined
20171.3 undefined0.05 undefined0.04 undefined
20161.17 undefined0 undefined0.07 undefined
20151.32 undefined0.11 undefined-0.03 undefined
20141.1 undefined0.06 undefined0.01 undefined
20130.96 undefined0.08 undefined0.04 undefined
20120.91 undefined0.09 undefined0.09 undefined
20110.91 undefined0.13 undefined0.09 undefined
20101.3 undefined0.28 undefined0.12 undefined
20091.54 undefined0.33 undefined0.26 undefined
20089.47 undefined2.05 undefined-0.38 undefined
20078.59 undefined1.9 undefined0.75 undefined

Instem business model

Instem PLC is a company specialized in providing software solutions for the health and life sciences. It is headquartered in Abingdon, Oxfordshire and operates internationally. The company was founded in 2000 and has been listed on the London Stock Exchange since 2004. Instem's business model is based on helping life science companies optimize and automate their workflows. They offer a wide range of software products tailored to the specific needs of their customers. This includes systems for documenting animal experiments, clinical data collection, and solutions for regulatory drug submissions. One of Instem's key divisions is the Preclinical Solutions Division, which helps life science companies effectively plan and conduct their preclinical studies. The products in this division support the creation of study protocols, planning experimental procedures, and documenting study results. Additionally, customers of the Preclinical Solutions Division can access assistance with data collection and analysis, as well as comprehensive consulting services. Another important division of Instem is the Clinical Solutions Division, which supports clinical research facilities in conducting clinical trials. Their solutions include clinical data collection, study monitoring, and data submission to regulatory authorities. The Clinical Solutions Division also provides support for quality control and the production of statistical reports. Instem is also active in other areas, such as in vitro diagnostics and chemical approval. In these fields, the company offers a range of software solutions that aid in data collection, analysis, and reporting. A key factor that sets Instem apart from its competitors is its close collaboration with the life science community. The company works closely with customers, regulatory agencies, and interest groups to ensure that its products meet industry requirements and standards. In addition, the company has established close relationships with leading clinical and research institutions worldwide. In summary, Instem PLC is a significant provider of software solutions for the health and life sciences. The company has experienced impressive growth in recent years and strengthened its position in key market segments. Instem is well positioned to continue benefiting from the increasing demand for software solutions in the health and life sciences industry. Instem is one of the most popular companies on Eulerpool.com.

Instem SWOT Analysis

Strengths

Instem PLC possesses several strengths that contribute to its success in the market. These include:

  • Strong financial performance and stability
  • Wide range of innovative and high-quality software solutions
  • Well-established reputation and extensive industry knowledge
  • Global presence with a strong customer base
  • Experienced and skilled workforce

Weaknesses

Despite its strengths, Instem PLC also faces certain weaknesses that could pose challenges. These include:

  • Dependence on specific industries for revenue
  • Limited product diversification
  • Reliance on key clients for a significant portion of sales

Opportunities

Instem PLC can capitalize on the following opportunities to further grow and expand its business:

  • Increasing demand for software solutions in the life sciences industry
  • Expansion into emerging markets with untapped potential
  • Acquisition of complementary businesses to enhance product portfolio
  • Technological advancements providing new avenues for innovation

Threats

However, there are certain threats that Instem PLC needs to consider and mitigate:

  • Intense competition from established software providers
  • Economic downturns impacting customer spending
  • Changing regulations and compliance requirements
  • Vulnerability to data breaches and cybersecurity risks

Instem historical P/E ratio, EBIT, and P/S ratio.

Instem shares outstanding

The number of shares was Instem in 2023 — This indicates how many shares 23.686 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Instem earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Instem's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Instem’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Instem's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Instem.

Eulerpool ESG Scorecard© for the Instem stock

Eulerpool World ESG Rating (EESG©)

51/ 100

🌱 Environment

29

👫 Social

74

🏛️ Governance

51

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Instem list of shareholders

%
Name
Stocks
Change
Date
8.12 % BGF Investment Management Limited1,953,450256,0008/30/2023
6.65 % Samson Rock Capital LLP1,600,601150,00010/13/2023
5.73 % Sand Grove Capital Management LLP1,377,945765,89510/11/2023
5.52 % Gare (David)1,326,865788,4389/4/2023
5.40 % Gresham House Asset Management Limited1,300,0007,4225/9/2023
4.64 % Alto Invest1,115,247-184,75311/25/2022
4.18 % Wasatch Global Investors Inc1,004,903104,9038/30/2023
4.16 % Aberdeen Standard Investments (Edinburgh)1,000,000760,1605/9/2023
3.95 % Eiffel Investment Group S.A.S.951,298-148,7028/30/2023
3.78 % Charles Stanley & Co. Limited909,080-352,14310/12/2023
1
2
3
4
5
...
10

Instem Executives and Management Board

Mr. Philip Reason
Instem Chief Executive Officer, Executive Director
Compensation 279,000
Mr. Nigel Goldsmith
Instem Chief Financial Officer, Company Secretary, Executive Director (since 2011)
Compensation 161,000
Mr. David Gare
Instem Non-Executive Chairman of the Board
Compensation 65,000
Mr. Michael McGoun72
Instem Non-Executive Independent Director
Compensation 40,000
Mr. David Sherwin
Instem Non-Executive Director (since 2010)
Compensation 33,000
1
2

Instem Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Roche Holding Stock
Roche Holding
SupplierCustomer0,570,890,680,620,300,71
Liontrust Asset Mgmt Stock
Liontrust Asset Mgmt
SupplierCustomer0,310,650,230,720,720,78
Pfizer Stock
Pfizer
SupplierCustomer0,260,670,780,820,100,73
Gilead Sciences Stock
Gilead Sciences
SupplierCustomer0,260,50-0,210,730,740,35
Charles River Labs Intl Stock
Charles River Labs Intl
SupplierCustomer0,150,580,200,710,660,85
Biotoxtech Stock
Biotoxtech
SupplierCustomer-0,01-0,62-0,46-0,61-0,21-0,68
Abrdn Stock
Abrdn
SupplierCustomer-0,14-0,170,200,710,47-0,21
Bristol-Myers Squibb Stock
Bristol-Myers Squibb
SupplierCustomer-0,19-0,440,65-0,52-0,640,18
Dow Stock
Dow
SupplierCustomer-0,30-0,260,35-0,45-0,510,51
Gresham House Stock
Gresham House
SupplierCustomer-0,300,490,860,320,220,78
1
2

Most common questions regarding Instem

What values and corporate philosophy does Instem represent?

Instem PLC represents a strong set of values and a robust corporate philosophy. The company is committed to delivering innovative software solutions and services to the global life sciences industry. Instem fosters a culture of integrity, excellence, and collaboration to ensure the highest level of customer satisfaction. With a focus on advancing scientific research and improving regulatory compliance, Instem aims to enhance the efficiency and effectiveness of research organizations worldwide. By consistently prioritizing customer success and embracing technologies, Instem PLC is recognized as a leading provider of solutions that drive scientific knowledge and operational excellence in the life sciences domain.

In which countries and regions is Instem primarily present?

Instem PLC is primarily present in the United Kingdom, United States, and in several European countries. The company operates globally, providing software solutions and services for the life sciences industry. With its headquarters in the UK, Instem PLC has established a strong presence in key markets, serving clients across North America, Europe, and other parts of the world. As a leading provider of scientific data solutions, Instem PLC offers its innovative products and expertise to support research organizations, pharmaceutical companies, regulatory authorities, and contract research organizations across these regions.

What significant milestones has the company Instem achieved?

Instem PLC has achieved several significant milestones throughout its history. The company has successfully developed and delivered innovative software solutions for the life sciences industry. Instem PLC has been recognized for its contributions to the field, winning numerous industry awards and certifications. The company has formed strategic partnerships and collaborations, expanding its global reach and customer base. Instem PLC has also demonstrated consistent financial growth, with increased revenues and profitability over the years. Additionally, the company has received positive feedback from clients, reinforcing its reputation as a leading provider of software solutions for the life sciences industry.

What is the history and background of the company Instem?

Instem PLC is a leading provider of software solutions and services to the global life sciences industry. With over 30 years of experience, Instem has established itself as a trusted partner in providing innovative technology solutions for drug development, regulatory compliance, and research management. Founded in 1987, Instem has grown to become a renowned player in the life sciences space, serving over 500 customers worldwide. The company's comprehensive suite of software solutions spans the entire research lifecycle, enabling organizations to enhance productivity, streamline processes, and drive operational excellence. Instem PLC's dedication to delivering cutting-edge solutions has solidified its position as a key player in the life sciences industry.

Who are the main competitors of Instem in the market?

The main competitors of Instem PLC in the market include companies such as LabCorp, Medidata Solutions, Oracle Health Sciences, and Parexel International.

In which industries is Instem primarily active?

Instem PLC is primarily active in the healthcare and life sciences industry.

What is the business model of Instem?

Instem PLC is a leading provider of software solutions and services for the life sciences industry. The company primarily operates through its informatics solutions which help organizations streamline their research and development processes. Instem's software products facilitate data management, analysis, and compliance across various stages of the drug discovery and development lifecycle. By offering comprehensive solutions, Instem PLC enables organizations to improve efficiency, enhance decision-making, and accelerate time-to-market for new therapies. With a strong focus on technological innovation and domain expertise, Instem PLC continues to drive advancements in the life sciences industry.

What is the P/E ratio of Instem 2024?

The Instem P/E ratio is 21.41.

What is the P/S ratio of Instem 2024?

The Instem P/S ratio is 2.59.

What is the AlleAktien quality score of Instem?

The AlleAktien quality score for Instem is 6/10.

What is the revenue of Instem 2024?

The expected Instem revenue is 75.86 M GBP.

How high is the profit of Instem 2024?

The expected Instem profit is 9.18 M GBP.

What is the business model of Instem

Instem PLC is a UK-based company specializing in software and information solutions for the life sciences sector. The company offers a wide range of products and services aimed at supporting and accelerating research and development processes. Translation: Instem PLC is a UK-based company specializing in software and information solutions for the life sciences sector. The company offers a wide range of products and services aimed at supporting and accelerating research and development processes.

What is the Instem dividend?

Instem pays a dividend of 0 GBP distributed over payouts per year.

How often does Instem pay dividends?

The dividend cannot currently be calculated for Instem or the company does not pay out a dividend.

What is the Instem ISIN?

The ISIN of Instem is GB00B3TQCK30.

What is the Instem WKN?

The WKN of Instem is A1C7NS.

What is the Instem ticker?

The ticker of Instem is INS.L.

How much dividend does Instem pay?

Over the past 12 months, Instem paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Instem is expected to pay a dividend of 0 GBP.

What is the dividend yield of Instem?

The current dividend yield of Instem is .

When does Instem pay dividends?

Instem pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Instem?

Instem paid dividends every year for the past 0 years.

What is the dividend of Instem?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Instem located?

Instem is assigned to the 'Health' sector.

Wann musste ich die Aktien von Instem kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Instem from 7/21/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 7/21/2024.

When did Instem pay the last dividend?

The last dividend was paid out on 7/21/2024.

What was the dividend of Instem in the year 2023?

In the year 2023, Instem distributed 0 GBP as dividends.

In which currency does Instem pay out the dividend?

The dividends of Instem are distributed in GBP.

All fundamentals about Instem

Our stock analysis for Instem Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Instem Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.